Psychology & Intimacy Creatine as a Treatment for Depression July 19, 2026 Rebecca Shoemaker The familiar staple of athletic performance enhancement, creatine, is now the subject of burgeoning scientific inquiry into its potential to alleviate symptoms of depression. A comprehensive systematic review published in…
Sexual Health & Medical Wellness Chlamydia pneumoniae Implicated in Alzheimer’s Disease Progression, Opening New Avenues for Diagnosis and Treatment July 15, 2026 Susilo Ahmad A groundbreaking study conducted by researchers at Cedars-Sinai has revealed a previously unrecognized link between a common respiratory bacterium, Chlamydia pneumoniae, and Alzheimer’s disease. The findings suggest that this bacterium,…
Sexual Health & Medical Wellness Zoliflodacin Emerges as Promising Single-Dose Oral Treatment Against Growing Threat of Drug-Resistant Gonorrhea July 10, 2026 Susilo Ahmad Researchers are testing a new oral medication called zoliflodacin that could offer a simpler way to treat gonorrhea, especially strains that no longer respond well to existing antibiotics. In a…
Sexual Health & Medical Wellness Chlamydia Pneumoniae Infection Linked to Alzheimer’s Disease Progression, Opening New Avenues for Treatment and Early Detection July 8, 2026 Susilo Ahmad A groundbreaking study conducted by researchers at Cedars-Sinai has revealed a compelling connection between a common respiratory bacterium, Chlamydia pneumoniae, and the progression of Alzheimer’s disease. The findings, published in…
Psychology & Intimacy New Research Challenges Long-Held Assumptions in Cerebellar Neuroscience, Potentially Reshaping Treatment for Neurological Disorders July 3, 2026 Rebecca Shoemaker New research from a Virginia Tech neuroscientist at the Fralin Biomedical Research Institute at VTC is raising questions about a long-standing approach to studying chronic neurological conditions such as dystonia,…
Sexual Health & Medical Wellness Zoliflodacin Emerges as a Promising Single-Dose Oral Treatment Against Growing Threat of Drug-Resistant Gonorrhea June 25, 2026 Susilo Ahmad Researchers are testing a new oral medication called zoliflodacin that could offer a simpler way to treat gonorrhea, especially strains that no longer respond well to existing antibiotics. In a…
Sexual Health & Medical Wellness Chlamydia Pneumoniae Implicated in Alzheimer’s Progression, Opening New Avenues for Treatment and Early Detection June 15, 2026 Susilo Ahmad A groundbreaking study by researchers at Cedars-Sinai has revealed a compelling connection between a common respiratory bacterium, Chlamydia pneumoniae, and the development and progression of Alzheimer’s disease. The findings, published…
Psychology & Intimacy Immunotherapy Offers Promising New Avenue for Treatment-Resistant Depression, University of Bristol Study Reveals June 4, 2026 Rebecca Shoemaker A groundbreaking clinical trial led by researchers at the University of Bristol has unveiled a potentially transformative approach to treating difficult-to-manage depression, suggesting that immunotherapy could offer a novel therapeutic…
Sexual Health & Medical Wellness Zoliflodacin Emerges as a Promising Single-Dose Oral Treatment for Gonorrhea Amid Rising Antibiotic Resistance June 4, 2026 Susilo Ahmad In a significant development poised to revolutionize the treatment of gonorrhea, researchers have unveiled compelling results for a new oral medication named zoliflodacin. This novel antibiotic, designed to combat increasingly…
Sexual Health & Medical Wellness Chlamydia Pneumoniae Infection Linked to Alzheimer’s Disease Progression, Opening New Avenues for Treatment and Early Diagnosis. May 31, 2026 Susilo Ahmad A groundbreaking study conducted by researchers at Cedars-Sinai has revealed a significant connection between a common respiratory bacterium, Chlamydia pneumoniae, and the progression of Alzheimer’s disease. The findings, published in…
